| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs6430553 | X-12095--N1-methyl-3-pyridone-4-carboxamide | T/C | 7269 | 0.39 | -0.018 (0.003) | 6.29·10-12 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs6430553 |
| Chromosomal location | Chr2: 135,347,870 (2q21.3) |
| Gene (distance) | ACMSD (0) |
| Predicted causal gene | ACMSD |
| Gene/protein classification | - |
| Metabolite (Pathway) | X-12095--N1-methyl-3-pyridone-4-carboxamide (NAD metabolism; Nucleotide) |
| Biochemical locus-metabolite relationship | ACMSD encodes alpha-Amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, the key enzyme regulating de novo synthesis of NAD from tryptophan [16807375]. X-12095 was identified as N1-methyl-3-pyridone-4-carboxamide, an endproduct of NAD degradation [12694300] |
| eQTL associations | - |
| Medical information | |
|---|---|
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information | |
|---|---|
| ChEMBL ID | - |
| Drug information | - |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








